Abstract
Introduction: Seasonal allergic rhinitis (SAR) is a common health condition that is associated with an increased risk for bronchial asthma. Besides conventional medicine, treatments from traditional, complementary and integrative medicine are widely used by individuals with SAR. This review aims to systematically summarize evidence on the efficacy, effectiveness, and safety of European/Western phytotherapy (PT) and medications from anthroposophic medicine (AM) in individuals with SAR. Methods: Four electronic databases were screened for clinical studies published between January 1990 and March 2023. The results were qualitatively synthesized and the study quality was assessed. Results: In total, 14 studies were included, 11 from European/Western PT and three from AM. About half of the studies were rated as being of sufficient quality. The most frequently studied plant was Petasites hybridus (butterbur), showing beneficial effects on immunological parameters, subjective symptoms, and nasal airflow. Beneficial immunological and clinical effects were also shown for an herbal preparation combining Citrus limonis (lemon) and Cydonia oblonga (quince). The medications examined by studies of sufficient quality were judged to be safe. Conclusion: In summary, this systematic review highlights two herbal preparations, one from European/Western PT and one from AM, that appear to be promising options in the treatment of SAR.
Journal Section:
Clinical Allergy – Systematic Review
References
1.
Savouré
M
, Bousquet
J
, Jaakkola
JJ
, Jaakkola
MS
, Jacquemin
B
, Nadif
R
. Worldwide prevalence of rhinitis in adults: a review of definitions and temporal evolution
. Clin Trans Allergy
. 2022
;12
(3
):e12130
. 2.
Nur Husna
SM
, Tan
H-TT
, Md Shukri
N
, Mohd Ashari
NS
, Wong
KK
. Allergic rhinitis: a clinical and pathophysiological overview
. Front Med
. 2022
;9
:e874114
. 3.
Bousquet
J
, Hellings
PW
, Agache
I
, Amat
F
, Annesi-Maesano
I
, Ansotegui
IJ
, et al. Allergic Rhinitis and its Impact on Asthma (ARIA) Phase 4 (2018): change management in allergic rhinitis and asthma multimorbidity using mobile technology
. J Allergy Clin Immunol
. 2019
;143
(3
):864
–79
. 4.
Meltzer
EO
, Bukstein
DA
. The economic impact of allergic rhinitis and current guidelines for treatment
. Ann Allergy Asthma Immunol
. 2011
;106
(2 Suppl
):12
–6
. 5.
Smith
M
, Berger
U
, Behrendt
H
, Bergmann
K-C
. Pollen and pollinosis
. Chem Immunol Allergy
. 2014
;100
:228
–33
. 6.
Holmberg
K
, Tonnel
AB
, Dreyfus
I
, Olsson
P
, Cougnard
J
, Mesbah
K
, et al. Desloratadine relieves nasal congestion and improves quality‐of‐life in persistent allergic rhinitis
. Allergy
. 2009
;64
(11
):1663
–70
. 7.
Patou
J
, De Smedt
H
, Van Cauwenberge
P
, Bachert
C
. Pathophysiology of nasal obstruction and meta‐analysis of early and late effects of levocetirizine
. Clin Exp Allergy
. 2006
;36
(8
):972
–81
. 8.
Bonizzoni
G
, Caminati
M
, Ridolo
E
, Landi
M
, Ventura
M
, Lombardi
C
, et al. Use of complementary medicine among patients with allergic rhinitis: an Italian nationwide survey
. Clin Mol Allergy
. 2019
;17
:2
–3
. 9.
Lombardi
C
, Musicco
E
, Rastrelli
F
, Bettoncelli
G
, Passalacqua
G
, Canonica
GW
. The patient with rhinitis in the pharmacy. A cross-sectional study in real life
. Asthma Res Pract
. 2015
;1
:4
–6
. 10.
Pokladnikova
J
, Park
A-L
, Draessler
J
, Lukacisinova
A
, Krcmova
I
. The use of complementary and alternative medicine by adults with allergies: a Czech national representative survey
. BMC Complement Med Ther
. 2021
;21
(1
):171
–8
. 11.
Schilcher
H
Leitfaden phytotherapie. Munich: urban & fischer
. Elsevier
; 2016
. Vol. Vol. 5
.12.
Thomet
OA
, Wiesmann
UN
, Schapowal
A
, Bizer
C
, Simon
H-U
. Role of petasin in the potential anti-inflammatory activity of a plant extract of Petasites hybridus
. Biochem Pharmacol
. 2001
;61
(8
):1041
–7
. 13.
Mahmood
MS
, Gilani
A
, Khwaja
A
, Rashid
A
, Ashfaq
M
. The in vitro effect of aqueous extract of Nigella sativa seeds on nitric oxide production
. Phytother Res
. 2003
;17
(8
):921
–4
. 14.
Huber
R
, Stintzing
FC
, Briemle
D
, Beckmann
C
, Meyer
U
, Gründemann
C
. In vitro antiallergic effects of aqueous fermented preparations from Citrus and Cydonia fruits
. Planta Med
. 2012
;78
(4
):334
–40
. 15.
Guo
R
, Pittler
M
. Petasites hybridus (butterbur) for treating allergic rhinitis
. Focus Altern Complement Ther
. 2007
;12
(2
):81
–4
. 16.
Moher
D
, Liberati
A
, Tetzlaff
J
, Altman
DG
; PRISMA Group
. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement
. Ann Intern Med
. 2009
;151
(4
):264
–W64
. 17.
Zingg
W
, Castro-Sanchez
E
, Secci
F
, Edwards
R
, Drumright
L
, Sevdalis
N
, et al. Innovative tools for quality assessment: integrated quality criteria for review of multiple study designs (ICROMS)
. Publ Health
. 2016
;133
:19
–37
. 18.
Ansari
MA
, Ansari
NA
, Junejo
SA
. Montelukast versus nigella sativa for management of seasonal allergic rhinitis: a single blind comparative clinical trial
. Pak J Med Sci
. 2010
;26
(2
):249
–54
.19.
Bernstein
DI
, Bernstein
CK
, Deng
C
, Murphy
KJ
, Bernstein
IL
, Bernstein
JA
, et al. Evaluation of the clinical efficacy and safety of grapeseed extract in the treatment of fall seasonal allergic rhinitis: a pilot study
. Ann Allergy Asthma Immunol
. 2002
;88
(3
):272
–8
. 20.
Dumitru
AF
, Shamji
M
, Wagenmann
M
, Hindersin
S
, Scheckenbach
K
, Greve
J
, et al. Petasol butenoate complex (Ze 339) relieves allergic rhinitis–induced nasal obstruction more effectively than desloratadine
. J Allergy Clin Immunol
. 2011
;127
(6
):1515
–21.e6
. 21.
Gray
RD
, Haggart
K
, Lee
DK
, Cull
S
, Lipworth
BJ
. Effects of butterbur treatment in intermittent allergic rhinitis: a placebo-controlled evaluation
. Ann Allergy Asthma Immunol
. 2004
;93
(1
):56
–60
. 22.
Käufeler
R
, Polasek
W
, Brattström
A
, Koetter
U
. Efficacy and safety of butterbur herbal extract Ze 339 in seasonal allergic rhinitis: postmarketing surveillance study
. Adv Ther
. 2006
;23
(2
):373
–84
. 23.
Lee
D
, Carstairs
I
, Haggart
K
, Jackson
C
, Currie
G
, Lipworth
B
. Butterbur, a herbal remedy, attenuates adenosine monophosphate induced nasal responsiveness in seasonal allergic rhinitis
. Clin Exp Allergy
. 2003
;33
(7
):882
–6
. 24.
Mittman
P
. Randomized, double-blind study of freeze-dried Urtica dioica in the treatment of allergic rhinitis
. Planta Med
. 1990
;56
(1
):44
–7
. 25.
Schapowal
A
; Petasites Study Group
. Randomised controlled trial of butterbur and cetirizine for treating seasonal allergic rhinitis
. BMJ
. 2002
;324
(7330
):144
–6
. 26.
Schapowal
A
; Petasites Study Group
. Butterbur Ze339 for the treatment of intermittent allergic rhinitis: dose-dependent efficacy in a prospective, randomized, double-blind, placebo-controlled study
. AOHNS
. 2004
;130
(12
):1381
–6
. 27.
Schapowal
A
; Study Group
. Treating intermittent allergic rhinitis: a prospective, randomized, placebo and antihistamine‐controlled study of Butterbur extract Ze 339
. Phytother Res
. 2005
;19
(6
):530
–7
. 28.
Wilson
D
, Evans
M
, Guthrie
N
, Sharma
P
, Baisley
J
, Schonlau
F
, et al. A randomized, double-blind, placebo-controlled exploratory study to evaluate the potential of pycnogenol for improving allergic rhinitis symptoms
. Phytother Res
. 2010
;24
(8
):1115
–9
. 29.
Baars
EW
, De Bruin
A
. The effect of Gencydo injections on hayfever symptoms: a therapeutic causality report
. J Altern Complement Med
. 2005
;11
(5
):863
–9
. 30.
Baars
EW
, Jong
M
, Nierop
AF
, Boers
I
, Savelkoul
HF
. Citrus/cydonia compositum subcutaneous injections versus nasal spray for seasonal allergic rhinitis: a randomized controlled trial on efficacy and safety
. ISRN Allergy
. 2011
;2011
:e836051
. 31.
Hoffmann
A
, Klein
S
, Gründemann
C
, Garcia-Käufer
M
, Wolf
U
, Huber
R
. Efficacy of a nasal spray from Citrus limon and cydonia oblonga for the treatment of hay fever symptoms—a randomized, placebo controlled cross‐over study
. Phytother Res
. 2016
;30
(9
):1481
–6
. 32.
Thomet
O
, Wiesmann
U
, Blaser
K
, Simon
HU
. Differential inhibition of inflammatory effector functions by petasin, isopetasin and neopetasin in human eosinophils
. Clin Exp Allergy
. 2001
;31
(8
):1310
–20
. 33.
Gex-Collet
C
, Imhof
L
, Brattström
A
, Pichler
WJ
, Helbling
A
. The butterbur extract petasin has no effect on skin test reactivity induced by different stimuli: a randomized, double-blind crossover study using histamine, codeine, methacholine, and aeroallergen solutions
. J Investig Allergol Clin Immunol
. 2006
;16
(3
):156
–61
.34.
Urda
L
, Kreuter
MH
, Drewe
J
, Boonen
G
, Butterweck
V
, Klimkait
T
. The petasites hybridus CO2 extract (Ze 339) blocks SARS-CoV-2 replication in vitro
. Viruses
. 2022
;14
(1
):106
–13
. 35.
Gründemann
C
, Papagiannopoulos
M
, Lamy
E
, Mersch-Sundermann
V
, Huber
R
. Immunomodulatory properties of a lemon-quince preparation (Gencydo®) as an indicator of anti-allergic potency
. Phytomedicine
. 2011
;18
(8–9
):760
–8
. 36.
Baars
E
, Savelkoul
H
. Citrus/Cydonia comp. can restore the immunological balance in seasonal allergic rhinitis-related immunological parameters in vitro
. Mediators Inflamm
. 2008
;2008
:496467
. 37.
Gagnier
JJ
, Boon
H
, Rochon
P
, Moher
D
, Barnes
J
, Bombardier
C
, et al. Reporting randomized, controlled trials of herbal interventions: an elaborated CONSORT statement
. Ann Int Med
. 2006
;144
(5
):364
–7
. © 2024 S. Karger AG, Basel
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
2024
You do not currently have access to this content.
